142570-80-7

Upstream product

• 53100-33-7 L-Ala-OPAc 
• 54837-14-8 2-(benzyloxyamino)acetic acid 
• 142570-82-9 H(BzlO)Gly-OSu 
• 128857-81-8 H-Ala-OPac*TFA 

Downstream Products

• 142570-79-4 Boc-3-OBzl 
• 142570-78-3 Boc-2-OBzl 
• 142570-84-1 Boc-Ala-(BzlO)Gly-Ala-OH 
• 183803-71-6 (S)-2-{2-[Benzyloxy-((S)-2-{(S)-2-[(S)-2-(2-{benzyloxy-[(S)-2-((S)-2-tert-butoxycarbonylamino-propionylamino)-propionyl]-amino}-acetylamino)-propionylamino]-propionylamino}-propionyl)-amino]-acetylamino}-propionic acid benzyl ester 
• 183803-78-3 (S)-2-{2-[((S)-2-{(S)-2-[(S)-2-(2-{[(S)-2-((S)-2-Amino-propionylamino)-propionyl]-benzyloxy-amino}-acetylamino)-propionylamino]-propionylamino}-propionyl)-benzyloxy-amino]-acetylamino}-propionic acid benzyl ester 
• 183803-70-5 (S)-2-(2-{Benzyloxy-[(S)-2-((S)-2-benzyloxycarbonylamino-propionylamino)-propionyl]-amino}-acetylamino)-propionic acid 2-oxo-2-phenyl-ethyl ester 
• 183803-68-1 (S)-2-(2-{Benzyloxy-[(S)-2-((S)-2-tert-butoxycarbonylamino-propionylamino)-propionyl]-amino}-acetylamino)-propionic acid 2-oxo-2-phenyl-ethyl ester 
• 183803-77-2 (S)-2-(2-{Benzyloxy-[(S)-2-((S)-2-benzyloxycarbonylamino-propionylamino)-propionyl]-amino}-acetylamino)-propionic acid 
• 183803-75-0 (S)-2-(2-{Benzyloxy-[(S)-2-((S)-2-tert-butoxycarbonylamino-propionylamino)-propionyl]-amino}-acetylamino)-propionic acid 
• 183803-73-8 (S)-2-{2-[((S)-2-Amino-propionyl)-benzyloxy-amino]-acetylamino}-propionic acid 2-oxo-2-phenyl-ethyl ester 
• 142570-83-0 Boc-Ala-(BzlO)Gly-Ala-OPac 

Relevant academic research and scientific papers

Iron(III) complex of a trihydroxamate ligand with an Ala-Ala-(HO)Gly-Ala sequence as a model for ferrioxamines. Formation of well-defined peptide loop structure

A dodecapeptide trihydroxamate ligand forms a well-defined chiral complex with iron(III) in which this small linear peptide assumes a unique loop conformation, uncommon to protein structures. The complex exhibits siderophore activity for a test microorganism.

N-Hydroxy Amides. X. Synthesis of a Nonapeptide with an Ala-(HO)Gly-Ala Sequence and Its Spectral and Iron(III) Holding Properties

A nonapeptide with an Ala-(HO)Gly-Ala sequence has been synthesized via condensation of appropriately protected tripeptide units. 1H NMR and CD spectral data indicate that the nonapeptide has a disordered structure in DMSO and water.The peptide forms a 1: